CEO Magazine: Qcil's Profits jumps 22% to Shs.40.7 billion on steady sales and smart pricing
Released On July 18, 2025
Qcil presented its financial results for the year ended March 31, 2025, and unveiled its expansion plans at its Annual General Meeting (AGM)
Latest Media Releases
Qcil Marks 20 Years with Groundbreaking for New Factory and Launch of Paediatric HIV/AIDS Medicine
Qcil, the region’s leading pharmaceutical manufacturer, today marked a double milestone, celebrating 20 years of pharmaceutical excellence in Sub-Saharan Africa and breaking ground for a new state-of-the-art manufacturing facility at its Luzira Industrial Park campus in Kampala.
Business Focus Magazine: Qcil Beyond Healing
DEFINED BY ITS HOLISTIC APPROACH TO WELLNESS, AFRICAN PHARMACEUTICAL MANUFACTURER QCIL IS ENABLING MORE FULFILLING LIVES ACROSS THE CONTINENT.
CEO Magazine: How Qcil is Rewriting Africa's Healthcare Story from Dependency to Self-Reliance
CEO Magazine: How Qcil is Rewriting Africa's Healthcare Story from Dependency to Self-Reliance
Qcil POSTS RECORD PROFITS AND ANNOUNCES AMBITIOUS EXPANSION
“This expansion will enable us to do more for our patients, our people, and our economy.” said Mr. Katongole.
Qcil Honours STEM Students from Uganda and Namibia
Quality Chemical Industries Limited (Qcil) held a certificate award ceremony to celebrate 45 Science, Technology, Engineering and Mathematics (STEM) interns, including 8 from Namibia, who successfully completed their internship program.